Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-DPD-15006240Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of pronase (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: Quality of EUS image. Planned start Jul 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-DPD-15006240.